HomeClinical TopicsFDA approves expanded use of Prevnar vaccine

FDA approves expanded use of Prevnar vaccine

The U.S. Food and Drug Administration (FDA) has approved the use of Prevnar 13, a pneumococcal 13-valent conjugate vaccine, in people 50 years and older. Read More.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content